Japan generics approvals set to up pressure on Zithromax, Valtrex
This article was originally published in Scrip
Executive Summary
The latest batch approval of generic drugs in Japan has attracted a large number of entrants for two molecules being opened up to their first such competition in the country, the oral macrolide antibiotic azithromycin (Pfizer's Zithromax) and the antiviral valaciclovir (GlaxoSmithKline's Valtrex).